Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS J1790 · per up to 5 MG

Droperidol injection

Products billed under this code include Droperidol.

Payment limit per up to 5 MG, by effective quarter, 2Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J1790

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Droperidol Hikma Pharmaceuticals USA Inc. 00143-9514-25 25 $133.70
Droperidol Hikma Pharmaceuticals USA Inc. 00143-9515-25 25 $133.70

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $5.348 −$2.776 up to 5 MG Droperidol injection v1, posted September 17, 2026
3Q26 $8.124 +$0.91 up to 5 MG Droperidol injection v1, posted September 15, 2026
2Q26 $7.214 +$0.034 up to 5 MG Droperidol injection v1, posted September 15, 2026
1Q26 $7.18 −$0.452 up to 5 MG Droperidol injection v1, posted September 15, 2026
4Q25 $7.632 +$2.271 up to 5 MG Droperidol injection v1, posted September 8, 2026
3Q25 $5.361 −$3.204 up to 5 MG Droperidol injection v1, posted March 10, 2026
2Q25 $8.565 – up to 5 MG Droperidol injection v1, posted March 10, 2026

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files